Targeted micelles with chemotherapeutics and gene drugs to inhibit the G1/S and G2/M mitotic cycle of prostate cancer

BACKGROUND: Chemotherapy and gene therapy are used in clinical practice for the treatment of castration-resistant prostate cancer. However, the poor efficiency of drug delivery and serious systemic side effects remain an obstacle to wider application of these drugs. Herein, we report newly designed...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yiran, Wang, Yanming, Meng, Li, Huang, Qingqing, Zhu, Yueqi, Cui, Wenguo, Cheng, Yingsheng, Liu, Ranlu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7796562/
https://www.ncbi.nlm.nih.gov/pubmed/33422073
http://dx.doi.org/10.1186/s12951-020-00756-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7796562/
https://www.ncbi.nlm.nih.gov/pubmed/33422073
http://dx.doi.org/10.1186/s12951-020-00756-6

Ejemplares similares